Nathan Hatton

730 total citations
29 papers, 503 citations indexed

About

Nathan Hatton is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nathan Hatton has authored 29 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nathan Hatton's work include Pulmonary Hypertension Research and Treatments (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). Nathan Hatton is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). Nathan Hatton collaborates with scholars based in United States, United Kingdom and Cyprus. Nathan Hatton's co-authors include John Ryan, Rodney A. Rhoades, Maureen A. Harrington, Najia Jin, Lindsay C. Bowman, Stephen L. Archer, Amer M. Johri, Shelby Kutty, Jessica Huston and Lian Tian and has published in prestigious journals such as Circulation, American Journal of Respiratory and Critical Care Medicine and Free Radical Biology and Medicine.

In The Last Decade

Nathan Hatton

23 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Hatton United States 11 288 174 129 69 61 29 503
Pablo Íñigo Spain 11 202 0.7× 82 0.5× 156 1.2× 45 0.7× 129 2.1× 22 583
Ligang Liu China 13 156 0.5× 104 0.6× 93 0.7× 45 0.7× 158 2.6× 72 452
Brian Hayes Ireland 15 131 0.5× 48 0.3× 77 0.6× 61 0.9× 82 1.3× 49 505
Monika Kasztura Poland 14 66 0.2× 226 1.3× 117 0.9× 44 0.6× 41 0.7× 33 690
Xiaoyun Luo China 8 161 0.6× 92 0.5× 191 1.5× 34 0.5× 94 1.5× 23 468
Noemi Michetti Italy 9 64 0.2× 123 0.7× 137 1.1× 124 1.8× 71 1.2× 11 612
Gael B. Morrow United Kingdom 10 126 0.4× 44 0.3× 75 0.6× 70 1.0× 50 0.8× 17 509
Kerrie A. Smith United Kingdom 14 275 1.0× 106 0.6× 70 0.5× 73 1.1× 76 1.2× 18 640
Amal Abdul‐Hafez United States 12 307 1.1× 138 0.8× 121 0.9× 44 0.6× 70 1.1× 20 595

Countries citing papers authored by Nathan Hatton

Since Specialization
Citations

This map shows the geographic impact of Nathan Hatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Hatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Hatton more than expected).

Fields of papers citing papers by Nathan Hatton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Hatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Hatton. The network helps show where Nathan Hatton may publish in the future.

Co-authorship network of co-authors of Nathan Hatton

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Hatton. A scholar is included among the top collaborators of Nathan Hatton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Hatton. Nathan Hatton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leary, Peter J., Sumeet Panjabi, John M. Hartney, et al.. (2025). Location of Care Delivery for Pulmonary Arterial Hypertension in the United States. American Journal of Respiratory and Critical Care Medicine. 211(4). 619–627. 1 indexed citations
2.
Dodson, Mark, Kristina Allen‐Brady, J. B. Stevens, et al.. (2025). Rare variants in STAB2 in patients with chronic thromboembolic pulmonary hypertension. ERJ Open Research. 11(4). 1322–2024.
4.
Hatton, Nathan, et al.. (2023). Inspiratory Muscle Training While Hospitalized With Acute COVID-19 Respiratory Failure. Journal of Acute Care Physical Therapy. 14(3). 134–142. 3 indexed citations
5.
Tonna, Joseph E., Ben J. Brintz, Tyler Bardsley, et al.. (2023). A randomized, double-blinded, placebo-controlled clinical trial of sterile filtered human amniotic fluid for treatment of COVID-19. BMC Infectious Diseases. 23(1). 864–864.
7.
Hatton, Nathan, Emily Beck, Meganne Ferrel, et al.. (2022). Imaging in Pulmonary Vascular Disease—Understanding Right Ventricle‐Pulmonary Artery Coupling. Comprehensive physiology. 12(4). 3705–3730. 4 indexed citations
9.
Selzman, Craig H., Joseph E. Tonna, Chloe R. Skidmore, et al.. (2021). A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC Research Notes. 14(1). 32–32. 11 indexed citations
10.
Jacobs, Joshua A., Tara L. Jones, Stephen H. McKellar, et al.. (2020). Management of Pulmonary Arterial Hypertension. Current Cardiovascular Risk Reports. 15(1). 2–2. 49 indexed citations
11.
Jacobs, Joshua A., et al.. (2020). Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension. Frontiers in Medicine. 7. 81–81. 12 indexed citations
12.
Timbrook, Tristan T., Polina Kukhareva, Nathan Hatton, et al.. (2020). A Pathway for Community-Acquired Pneumonia With Rapid Conversion to Oral Therapy Improves Health Care Value. Open Forum Infectious Diseases. 7(11). ofaa497–ofaa497. 11 indexed citations
13.
Cirulis, Meghan M., Jessica Huston, Partha Sardar, et al.. (2018). Right-to-left ventricular end diastolic diameter ratio in severe sepsis and septic shock. Journal of Critical Care. 48. 307–310. 6 indexed citations
14.
Cirulis, Meghan M., Lyska L. Emerson, David A. Bull, et al.. (2016). Pulmonary Arterial Hypertension in Primary Amyloidosis. Pulmonary Circulation. 6(2). 244–248. 9 indexed citations
15.
Ryan, John, Jessica Huston, Shelby Kutty, et al.. (2015). Right Ventricular Adaptation and Failure in Pulmonary Arterial Hypertension. Canadian Journal of Cardiology. 31(4). 391–406. 150 indexed citations
16.
Scholand, Mary Beth, et al.. (2012). Interstitial Lung Disease in Systemic Sclerosis: Diagnosis and Management. 1(S1). 8 indexed citations
17.
Hatton, Nathan, Tracy Frech, Benjamin Smith, et al.. (2011). Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis. International Journal of Clinical Practice. 65(172). 35–43. 10 indexed citations
18.
Frech, Tracy, Nathan Hatton, Boaz A. Markewitz, et al.. (2010). The Vascular Microenvironment and Systemic Sclerosis. International Journal of Rheumatology. 2010. 1–6. 6 indexed citations
19.
Jin, Najia, et al.. (2000). H2O2-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells. Free Radical Biology and Medicine. 29(8). 736–746. 40 indexed citations
20.
Jin, Najia, Nathan Hatton, Darl R. Swartz, et al.. (2000). Hypoxia Activates Jun-N-Terminal Kinase, Extracellular Signal–Regulated Protein Kinase, and p38 Kinase in Pulmonary Arteries. American Journal of Respiratory Cell and Molecular Biology. 23(5). 593–601. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026